The 20 Best Diabetic Hyperglycemic Hyperosmolar Syndrome Doctors near Towson, MD

Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy is rated as a Distinguished provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Craig Haber is an Endocrinologist in Towson, Maryland. Dr. Haber is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Thyroid Cancer, and Anaplastic Thyroid Cancer.

Hui Peng is an Endocrinologist in Lutherville Timonium, Maryland. Dr. Peng is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Juvenile Primary Osteoporosis, Type 2 Diabetes (T2D), Thyroid Nodule, and Vitamin D Deficiency.

Rani Kulkarni is an Endocrinologist in Baltimore, Maryland. Dr. Kulkarni is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Thyroid Nodule.

Paul Sack is an Endocrinologist in Baltimore, Maryland. Dr. Sack is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hypothyroidism.

Jeffrey Alexander is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Alexander is rated as an Advanced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Transient Familial Hyperbilirubinemia, Thyroid Dysgenesis, Congenital Hypothyroidism, and Newborn Jaundice.

Marc Sokolow is a primary care provider, practicing in Geriatrics in Towson, Maryland. Dr. Sokolow is rated as an Advanced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Sitosterolemia, Fish Tapeworm Infection, Acute Cystitis, and High Cholesterol.

Narender Bharaj is a primary care provider, practicing in Internal Medicine in Parkville, Maryland. Dr. Bharaj is rated as an Advanced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Dementia, Anemia, Familial Hypertension, and Hypertension.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Gary Friedman is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Diabetic Hyperglycemic Hyperosmolar Syndrome, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Type 2 Diabetes (T2D).

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Pancreaticoduodenectomy.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Hormone Replacement Therapy (HRT).

Colleen Christmas is associate professor of medicine. Practicing geriatric medicine primary care and consultative geriatric medicine, she serves as the director of the Primary Care Leadership Track and faculty in the Colleges Advising Program at the Johns Hopkins University School of Medicine. Her academic interests include medical education, professional identity formation, nutrition and exercise in the elderly. She received her medical degree from the University of Connecticut John Dempsey Hospital. Dr. Christmas is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Peter M. Abadir is a geriatrician and translational researcher at Johns Hopkins University. He serves as the Principal Investigator of the Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research, where he leads interdisciplinary initiatives to advance innovations in aging and resilience science. His clinical focus includes frailty, cognitive decline, and age-related conditions, while his translational research bridges molecular biology, bioengineering, and geriatrics. Dr. Abadir is an Associate Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins School of Medicine and holds a joint appointment in Electrical and Computer Engineering at the Whiting School of Engineering. He also directs the Molecular Measurement Core of the Johns Hopkins Older Americans Independence Center and co-directs the Clinical Translation and Validation Core for the Artificial Intelligence and Technology Collaboratory. He currently serves as Chair of the MD Admissions Committee for the Johns Hopkins School of Medicine, overseeing the selection of the next generation of leaders in medicine. Additionally, Dr. Abadir is the Deputy Editor of the Journal of the American Geriatrics Society and serves on several other journal editorial boards. Among his research contributions, Dr. Abadir was among the first to describe the presence of a mitochondrial angiotensin system, providing new insights into cellular energy metabolism and aging. His pioneering work has also focused on biomarkers for frailty and cognitive decline, including circulating mitochondrial DNA and inflammation-related pathways. Notably, his research on the use tof topical angiotensin system blockers has introduced novel approaches to wound healing in aging populations. Dr. Abadir is a recipient of the Nathan Shock Scholar in Aging Award and the Frederick L. Brancati Excellence in Mentoring Award. Additionally, he has received the Johns Hopkins Institute for Excellence in Education Leadership and Mentorship Award and was inducted into the Johns Hopkins Distinguished Teaching Society, reflecting his outstanding contributions to mentorship and education. Dr. Abadir co-founded the Johns Hopkins Gerotech Incubator Program, which integrates medicine, engineering, and technology to develop solutions that enhance the health and independence of older adults. LinkedInhttps://www.linkedin.com/in/peter-abadir-87401715/. Dr. Abadir is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Dementia, Alzheimer's Disease, Vasoconstriction, and Muscle Atrophy.

Ahmed Ibrahim is a primary care provider, practicing in Geriatrics in Towson, Maryland. Dr. Ibrahim is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Cellulitis, Acute Pancreatitis, Sepsis, Gastrostomy, and Endoscopy.

Timothy Herlihy is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Herlihy is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Type 2 Diabetes (T2D).

Jin Gu is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Gu is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. Her top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, Bone Marrow Aspiration, and Endoscopy.

Mel Daly is a primary care provider, practicing in Geriatrics in Towson, Maryland. Dr. Daly is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Lymphedema, Anemia, Hypothyroidism, and Dementia.

Robert Vissing is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Vissing is rated as an Experienced provider by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and Type 2 Diabetes (T2D).